MedPath

HBM Pharma s.r.o.

🇸🇰Slovakia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

13

PHILIPPINES:10
SFDA:3

Drug Approvals

Bupibaric

Approval Date
Jul 14, 2025
PHILIPPINES

Fentamar

Approval Date
Jul 14, 2025
PHILIPPINES

Stadapram

Approval Date
Jul 14, 2025
PHILIPPINES

Midamarc

Approval Date
Jul 14, 2025
PHILIPPINES

Evexy

Approval Date
Jul 14, 2025
PHILIPPINES

Anesticaine

Approval Date
Jul 14, 2025
PHILIPPINES

Oxymarc

Approval Date
Jul 14, 2025
PHILIPPINES

Morphina

Approval Date
Jul 14, 2025
PHILIPPINES

Ketorzac

Approval Date
Jul 14, 2025
PHILIPPINES

Oxymarc

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.